347 related articles for article (PubMed ID: 19287824)
1. Pharma Dynamics: targeting safe, effective and affordable medication for South Africa and neighbouring countries.
Cardiovasc J Afr; 2009; 20(1):85. PubMed ID: 19287824
[No Abstract] [Full Text] [Related]
2. Merck Serono targets convenient, affordable medicines for patients at risk.
Cardiovasc J Afr; 2009; 20(1):77. PubMed ID: 19287822
[No Abstract] [Full Text] [Related]
3. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
't Hoen E
Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
[No Abstract] [Full Text] [Related]
4. Ethics and AIDS drugs.
Dowell W
Time; 1999 Jul; 154(2):49. PubMed ID: 10538646
[No Abstract] [Full Text] [Related]
5. No money, no meds.
Mabry M
Newsweek; 1999 Jul; 134(2):32-3. PubMed ID: 10538648
[No Abstract] [Full Text] [Related]
6. World Trade Organization still threatens supply of affordable AIDS drugs.
Hagmann M
Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300
[No Abstract] [Full Text] [Related]
7. Innovation and the WHO's essential medicines list: giving credit where credit is due.
Wertheimer AI; Santella TM
Res Social Adm Pharm; 2007 Mar; 3(1):137-44. PubMed ID: 17350562
[No Abstract] [Full Text] [Related]
8. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
Berger JM
Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
[No Abstract] [Full Text] [Related]
9. Africa could learn from India's burgeoning pharma sector.
Selvaraj S
BMJ; 2013 Aug; 347():f4235. PubMed ID: 23913693
[No Abstract] [Full Text] [Related]
10. The GO License: only part of the solution.
Batson A; Milstien JB
Health Aff (Millwood); 2008; 27(1):140-2. PubMed ID: 18180489
[TBL] [Abstract][Full Text] [Related]
11. Access to essential drugs, human rights and global justice.
Shalev C
Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
[No Abstract] [Full Text] [Related]
12. Laboratory monitoring of HIV--after access to antiretroviral drugs, the next challenge for the developing world.
Tucker T; Yeats J
S Afr Med J; 2001 Aug; 91(8):615. PubMed ID: 11584766
[No Abstract] [Full Text] [Related]
13. The cost of prescription drugs: rising concerns over equity, fairness and access to essential care.
Work DR; Domino ME
N C Med J; 2003; 64(6):270-4. PubMed ID: 14983614
[No Abstract] [Full Text] [Related]
14. [Access for all to quality drugs].
Videau JY
Med Trop (Mars); 2002; 62(4):396-400. PubMed ID: 12534178
[TBL] [Abstract][Full Text] [Related]
15. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
Spectar JM
Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
[No Abstract] [Full Text] [Related]
16. Reforming Canada's Access to Medicines Regime.
Elliott R
CMAJ; 2007 Jul; 177(3):270-1. PubMed ID: 17664453
[No Abstract] [Full Text] [Related]
17. Generic drugs battle moves from South Africa to Kenya.
Siringi S
Lancet; 2001 May; 357(9268):1600. PubMed ID: 11377665
[No Abstract] [Full Text] [Related]
18. Cut-rate AIDS.
Golden F
Time; 2001 Mar; 157(11):68. PubMed ID: 11276822
[No Abstract] [Full Text] [Related]
19. Reprivatizing pharmaceutical supplies in Africa.
Turshen M
J Public Health Policy; 2001; 22(2):198-225. PubMed ID: 11469153
[TBL] [Abstract][Full Text] [Related]
20. Cheap HIV drugs for developing countries.
Int J Epidemiol; 2001 Jun; 30(3):651-2. PubMed ID: 11460820
[No Abstract] [Full Text] [Related]
[Next] [New Search]
